Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rei Suzuki

Showing results (211-220 of 213) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 213 results.
Journal of Gastroenterology|November 18, 2025
Mortality and cancer risk in patients with chronic pancreatitis in japan: insights into the importance of surveillance for pancreatic cancerRyotaro Matsumoto, Kazuhiro Kikuta, Tetsuya Takikawa, et al.
Journal of Gastroenterology|November 30, 2024
Efficacy of liposomal irinotecan + 5-FU/LV vs. S-1 in gemcitabine-refractory metastatic pancreatic cancer: a real-world study using inverse probability of treatment weightingHiroshi Imaoka, Masafumi Ikeda, Satoshi Kobayashi, et al.
The Oncologist|March 2, 2026
Phase II study of maintenance trifluridine/tipiracil (TAS-102) plus bevacizumab after induction chemotherapy in metastatic colorectal cancerKatsuya Ota, Mamoru Uemura, Tsukasa Tanida, et al.
Pageof 22

Showing results (211-220 of 213) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 213 results.
Journal of Gastroenterology|November 18, 2025
Mortality and cancer risk in patients with chronic pancreatitis in japan: insights into the importance of surveillance for pancreatic cancerRyotaro Matsumoto, Kazuhiro Kikuta, Tetsuya Takikawa, et al.
Journal of Gastroenterology|November 30, 2024
Efficacy of liposomal irinotecan + 5-FU/LV vs. S-1 in gemcitabine-refractory metastatic pancreatic cancer: a real-world study using inverse probability of treatment weightingHiroshi Imaoka, Masafumi Ikeda, Satoshi Kobayashi, et al.
The Oncologist|March 2, 2026
Phase II study of maintenance trifluridine/tipiracil (TAS-102) plus bevacizumab after induction chemotherapy in metastatic colorectal cancerKatsuya Ota, Mamoru Uemura, Tsukasa Tanida, et al.
Pageof 22